These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7094938

  • 1. Serum 25 (OH) D and 24,25 (OH)2 levels in childhood nephrosis under different therapeutic regimens of steroid administration.
    Kano K, Suda T.
    Eur J Pediatr; 1982 Mar; 138(2):162-5. PubMed ID: 7094938
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D and parathyroid hormone status in children with the nephrotic syndrome and chronic mild glomerulonephritis.
    Chesney RW, Hamstra A, Rose P, DeLuca HF.
    Int J Pediatr Nephrol; 1984 Mar; 5(1):1-4. PubMed ID: 6715110
    [Abstract] [Full Text] [Related]

  • 3. Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids.
    Chesney RW, Mazess RB, Hamstra AJ, DeLuca HF, O'Reagan S.
    Lancet; 1978 Nov 25; 2(8100):1123-5. PubMed ID: 82684
    [Abstract] [Full Text] [Related]

  • 4. Serum concentrations of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in patients with various types of renal disease.
    Kano K, Nonoda A, Yoneshima H, Suda T.
    Clin Nephrol; 1980 Dec 25; 14(6):274-9. PubMed ID: 6970645
    [Abstract] [Full Text] [Related]

  • 5. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose.
    Klein RG, Arnaud SB, Gallagher JC, Deluca HF, Riggs BL.
    J Clin Invest; 1977 Jul 25; 60(1):253-9. PubMed ID: 874087
    [Abstract] [Full Text] [Related]

  • 6. A specific competitive protein binding assay for serum 24,25-dihydroxyvitamin D in normal children and patients with nephrotic syndrome.
    Shimotsuji T, Hiejima T, Seino Y, Yamaoka K, Ishii T, Ishida M, Matsuda S, Ikehara C, Yabuuchi H.
    Clin Chim Acta; 1980 Sep 25; 106(2):145-54. PubMed ID: 6967783
    [Abstract] [Full Text] [Related]

  • 7. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
    Bell NH, Stern PH, Pantzer E, Sinha TK, DeLuca HF.
    J Clin Invest; 1979 Jul 25; 64(1):218-25. PubMed ID: 312811
    [Abstract] [Full Text] [Related]

  • 8. Bone mineral content in nephrotic children on long-term, alternate-day prednisone therapy.
    Polito C, La Manna A, Todisco N, Cimmaruta E, Sessa G, Pirozzi M.
    Clin Pediatr (Phila); 1995 May 25; 34(5):234-6. PubMed ID: 7628164
    [Abstract] [Full Text] [Related]

  • 9. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
    Balsan S, Garabedian M, Liberman UA, Eil C, Bourdeau A, Guillozo H, Grimberg R, Le Deunff MJ, Lieberherr M, Guimbaud P, Broyer M, Marx SJ.
    J Clin Endocrinol Metab; 1983 Oct 25; 57(4):803-11. PubMed ID: 6309886
    [Abstract] [Full Text] [Related]

  • 10. Age and seasonal variations in the serum levels of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in normal humans.
    Kano K, Yoshida H, Yata J, Suda T.
    Endocrinol Jpn; 1980 Apr 25; 27(2):215-21. PubMed ID: 6967810
    [Abstract] [Full Text] [Related]

  • 11. Extrarenal synthesis of 1,25-dihydroxyvitamin D: sensitivity to glucocorticoid treatment.
    Adami S, Graziani G, Tartarotti D, Cappelli R, Casati S, Cantaluppi A, Braga V, Lo Cascio V.
    Clin Sci (Lond); 1987 Mar 25; 72(3):329-34. PubMed ID: 3493110
    [Abstract] [Full Text] [Related]

  • 12. Comparison of different regimens of prednisone therapy in frequently relapsing nephrotic syndrome.
    Wingen AM, Müller-Wiefel DE, Schärer K.
    Acta Paediatr Scand; 1990 Mar 25; 79(3):305-10. PubMed ID: 2333744
    [Abstract] [Full Text] [Related]

  • 13. Corticosteroid-responsive hypercalcemia with elevated serum 1-alpha, 25 dihydroxyvitamin D.
    Frame B, Parfitt AM.
    Ann Intern Med; 1980 Sep 25; 93(3):449-51. PubMed ID: 7436165
    [Abstract] [Full Text] [Related]

  • 14. Vitamin D metabolites in childhood nephrotic syndrome.
    Grymonprez A, Proesmans W, Van Dyck M, Jans I, Goos G, Bouillon R.
    Pediatr Nephrol; 1995 Jun 25; 9(3):278-81. PubMed ID: 7632510
    [Abstract] [Full Text] [Related]

  • 15. Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs.
    Jubiz W, Haussler MR, McCain TA, Tolman KG.
    J Clin Endocrinol Metab; 1977 Apr 25; 44(4):617-21. PubMed ID: 849976
    [Abstract] [Full Text] [Related]

  • 16. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW, Hollis BW, Bell NH, Epstein S.
    J Clin Invest; 1980 Oct 25; 66(4):782-91. PubMed ID: 7419719
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and total 24,25-dihydroxyvitamin D in human serum.
    Parviainen MT, Savolainen KE, Alhava EM, Mäenpää PH.
    Ann Clin Res; 1981 Feb 25; 13(1):26-33. PubMed ID: 6972726
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.